Blog

Aug 26, 2024, 20:43

Karen Knudsen: “Thinking Boldly and Believing in Yourself” with Mally Roncal and QVC

Karen Knudsen shared a post on LinkedIn:

“Thank you to Mally Roncal and QVC for hosting me on Over 50 and Fabulous recently to promote the Q50 campaign.

I am a member of the Q50 and was so excited to be on the show.

Mally and I talked about “Thinking Boldly and Believing in Yourself” which, as you all know, is a topic I’m passionate about as a woman in leadership.

Thinking boldly, having no limits, and having courage to do things you may not have been confident enough to do in your 20s are some of the things I’m grateful for at this stage of my life.

We also got to talk quite a bit about my work at the American Cancer Society and about cancer prevention and early detection, things women (and people) of all ages should always be mindful of.

Each of us has a role to play in cancer screening – speak to your doctor, know your personal risks due to your family history, and get appropriate screening. It’s also important to share this early detection message with your friends and family by saying “I love you, get screened.”

Another Over 50 and Fabulous airs this Friday at 8 pm ET on QVC followed by the 10 pm ET after show livestream on QVC.com and QVC’s Over 50 and Fabulous Facebook group”

No alt text provided for this image

Source: Karen Knudsen/LinkedIn

Karen E. Knudsen is the CEO of the American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN). Prior to joining ACS, Dr. Knudsen served as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health. She also served as president for the Association of American Cancer Institutes (AACI) and on the board of directors of the American Association for Cancer Research (AACR). She serves on the board of advisors for the National Cancer Institute and on 12 external advisory boards for NCI-designated cancer centers. She is an active member of several committees with the American Society for Clinical Oncology (ASCO), in addition to serving on other academic and for-profit advisory boards.